Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

474 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Effectiveness of insulin suppositories in diabetic patients.
Nishihata T, Kamada A, Sakai K, Yagi T, Kawamori R, Shichiri M. Nishihata T, et al. Among authors: kawamori r. J Pharm Pharmacol. 1989 Nov;41(11):799-801. doi: 10.1111/j.2042-7158.1989.tb06372.x. J Pharm Pharmacol. 1989. PMID: 2576055
Effect of sulfonylureas on switching to insulin therapy (twice-daily biphasic insulin aspart 30): comparison of twice-daily biphasic insulin aspart 30 with or without glimepiride in type 2 diabetic patients poorly controlled with sub-maximal glimepiride.
Ebato C, Shimizu T, Arakawa M, Mita T, Fujitani Y, Watada H, Kawamori R, Hirose T. Ebato C, et al. Among authors: kawamori r. Diabetes Res Clin Pract. 2009 Oct;86(1):31-6. doi: 10.1016/j.diabres.2009.07.008. Epub 2009 Aug 18. Diabetes Res Clin Pract. 2009. PMID: 19692134 Clinical Trial.
The IMPROVE study--a multinational, observational study in type 2 diabetes: baseline characteristics from eight national cohorts.
Valensi P, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Wenying Y; IMPROVE Study Group Expert Panel. Valensi P, et al. Among authors: kawamori r. Int J Clin Pract. 2008 Nov;62(11):1809-19. doi: 10.1111/j.1742-1241.2008.01917.x. Epub 2008 Sep 22. Int J Clin Pract. 2008. PMID: 18811598 Clinical Trial.
Safety and effectiveness of biphasic insulin aspart 30/70 (NovoMix 30) when switching from human premix insulin in patients with type 2 diabetes: subgroup analysis from the 6-month IMPROVE observational study.
Shah S, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shestakova M, Wenying Y, Valensi P; IMPROVE Study Group Expert Panel. Shah S, et al. Among authors: kawamori r. Int J Clin Pract. 2009 Apr;63(4):574-82. doi: 10.1111/j.1742-1241.2009.02012.x. Epub 2009 Feb 5. Int J Clin Pract. 2009. PMID: 19210701 Free PMC article. Clinical Trial.
Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix 30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE observational study.
Valensi P, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Wenying Y; IMPROVE Study Group Expert Panel. Valensi P, et al. Among authors: kawamori r. Int J Clin Pract. 2009 Mar;63(3):522-31. doi: 10.1111/j.1742-1241.2009.02002.x. Epub 2009 Jan 27. Int J Clin Pract. 2009. PMID: 19187170 Clinical Trial.
Intensification to biphasic insulin aspart 30/70 (BIAsp 30, NovoMix 30) can improve glycaemic control in patients treated with basal insulins: a subgroup analysis of the IMPROVE observational study.
Gumprecht J, Benroubi M, Borzi V, Kawamori R, Shaban J, Shah S, Shestakova M, Wenying Y, Ligthelm R, Valensi P; IMPROVE Study Group Expert Panel. Gumprecht J, et al. Among authors: kawamori r. Int J Clin Pract. 2009 Jun;63(6):966-72. doi: 10.1111/j.1742-1241.2009.02064.x. Int J Clin Pract. 2009. PMID: 19504715 Free PMC article. Clinical Trial.
474 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page